The current recommendation of Buy for Bio Rad Laboratories Inc (NYSE:BIO) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. This represents no change from the previous week and is the same ranking BIO has had from Portfolio Grader for 2 months.
The company ranks in the top half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, with a market value of $6.6 billion.
Currently, Portfolio Grader ranks the Health Care sector number 10 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Life Sciences Tools & Services industry group is ranked 19 among the 69 industry groups within the GICS sectors, placing it near the average in terms of the Navellier scoring system.
Bio Rad Laboratories has received above-average scores in 0 of the 8 fundamental areas evaluated by Portfolio Grader and average or below-average grades in 8 of the areas used in the ranking of company stocks.
BIO's operational scores are a source of great concern with a ranking for sales growth, operating margin and earnings growth that are substantially below average. Scores for visibility of earnings are a source of great concern with a ranking for earnings revisions, earnings surprises and earnings momentum that are worse than average. BIO's grades for return on equity and cash flow are worse than its industry group average. Bio Rad Laboratories' fundamental scores give BIO a place in the bottom quartile of the industry group.
Portfolio Grader uses the Navellier Proprietary Quantitative Score to view BIO's shares from the angle of risk/reward. This exclusive scoring system evaluates the relative value of BIO's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Based on this risk/reward calculation, the company currently scores well above-average in its industry group compared to its peers.
Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.
Commentary provided by UpTick Data Technologies.